Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Treace Medical Concepts, Inc. (TMCI)

25.19   -0.53 (-2.06%) 03-31 16:00
Open: 25.9 Pre. Close: 25.72
High: 25.905 Low: 25
Volume: 500,556 Market Cap: 1,541(M)

Technical analysis

as of: 2023-03-31 4:22:37 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 30.47     One year: 35.59
Support: Support1: 22.05    Support2: 19.54
Resistance: Resistance1: 26.09    Resistance2: 30.47
Pivot: 24.18
Moving Average: MA(5): 25.27     MA(20): 23.83
MA(100): 23.3     MA(250): 20.63
MACD: MACD(12,26): 0.7     Signal(9): 0.5
Stochastic oscillator: %K(14,3): 83.1     %D(3): 82.1
RSI: RSI(14): 61.2
52-week: High: 26.5  Low: 12.47
Average Vol(K): 3-Month: 418 (K)  10-Days: 333 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ TMCI ] has closed below upper band by 22.0%. Bollinger Bands are 14.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 25.93 - 26.06 26.06 - 26.14
Low: 24.69 - 24.86 24.86 - 24.97
Close: 24.94 - 25.2 25.2 - 25.37

Company Description

Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.

Headline News

Wed, 29 Mar 2023
Treace Shareholder Action Reminder - Treace Medical Concepts ... - Benzinga

Tue, 14 Mar 2023
'Dodged a bullet': How fall of SVB is affecting First Coast companies - The Business Journals

Thu, 09 Mar 2023
Shareholders might want to keep a close eye on Treace Medical Concepts, Inc. (NASDAQ:TMCI) after insiders sold US$4.9m stock earlier this year - Simply Wall St

Wed, 08 Mar 2023
Treace Medical Concepts Inc Up 19.77% To $24.23 After Earnings Beat - InvestorsObserver

Wed, 08 Mar 2023

Wed, 08 Mar 2023
Health Care Sector Update for 03/08/2023: LFST, TMCI, MESO, XLV ... - Nasdaq

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 56 (M)
Shares Float 34 (M)
% Held by Insiders 38.8 (%)
% Held by Institutions 49 (%)
Shares Short 1,820 (K)
Shares Short P.Month 1,970 (K)

Stock Financials

EPS -0.35
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.85
Profit Margin (%) -35.9
Operating Margin (%) -29.5
Return on Assets (ttm) -15.8
Return on Equity (ttm) -56.5
Qtrly Rev. Growth 52.9
Gross Profit (p.s.) 1.37
Sales Per Share 2.26
EBITDA (p.s.) -0.64
Qtrly Earnings Growth 0
Operating Cash Flow -29 (M)
Levered Free Cash Flow -32 (M)

Stock Valuations

PE Ratio -74.09
PEG Ratio 0
Price to Book value 13.61
Price to Sales 11.13
Price to Cash Flow -48.15

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.